Summary of the invention
Technical problem:The present invention seeks to develop a kind of technique that can improve iron protein succinylate dissolubility in water, and prepare iron protein succinylate oral administration solution preparation with this technique, the problems such as slightly solubility, the solution of this medicine in water is unstable to solve, free iron too high levels, be convenient to applying of this medicine.
Technical scheme:A kind of iron protein succinylate solubilization method of the present invention, take iron protein succinylate as crude drug, adds solubilizing agent, excipient and cosolvent, adds the aqueous slkali heated and stirred and dissolves, then add acid, regulates pH to 6.5-8.0pH.
Wherein, added solubilizing agent accounts for the crude drug total weight percent and is: the PEG-400 of the sodium lauryl sulphate of 0.1-1%, the poloxamer of 0.1-2%, 0.5%-10% or the beta-schardinger dextrin-of 5-20%.
Added excipient accounts for the crude drug total weight percent: the sorbitol of 5-10%.
Added cosolvent accounts for the crude drug total weight percent: the 1,2-PD of 5-10%.
Added aqueous slkali is the NaOH of 0.1-1mol/L or the KOH solution of 0.1-1mol/L, or the combination aqueous slkali of the KOH solution of the NaOH of 0.1-1mol/L and 0.1-1mol/L.
Added acid accounts for the crude drug total weight percent: the malic acid of the citric acid of 1-10%, the lactic acid of 1-10% or 1-10%.
The iron protein succinylate oral administration solution preparation of product configuration prepared by described method is: will in the settled solution of the iron protein succinylate after solubilising, add antiseptic, correctives and sweeting agent, after filtration, sterilizing, be made into iron protein succinylate oral administration solution preparation;
Added antiseptic accounts for the said preparation total weight percent: the propyl hydroxybenzoate sodium of 0.1-0.2% and the methyl hydroxybenzoate sodium of 0.1-0.2%;
Added correctives accounts for the said preparation total weight percent: Fructus Pyracanthae essence 1%, Fructus Mangifera Indicae essence 1%, the sub-essence 1% of tangerine or cherry essence 1%; Added sweeting agent accounts for the said preparation total weight percent: saccharin sodium 0.1-0.2% or steviosin 0.1-0.2%.
The oral administration solution preparation specification of preparing is 800mg/15ml iron protein succinylate oral administration solution; The oral administration solution preparation of preparing is after 2 μ m filter, then through 0.45 μ m or 0.22 μ m filtering with microporous membrane, and through 105~115 ℃ of sterilizing 20min of high temperature.
Beneficial effect:
1. this solubilising preparing process, improved the dissolubility of iron protein succinylate in water, the iron protein succinylate oral administration solution of developing, and it contains the free iron amount and is no more than 0.1% of total content.
2. the iron protein succinylate oral administration solution of developing, indices all can meet import drugs registered standard JX20000298, and other meet relevant every regulation under two oral solution items of Chinese Pharmacopoeia version in 2010.
3. the results of stability of iron protein succinylate oral administration solution shows, this preparation all belongs to well the stability of light and heat, tentative 2 years of the storage period under room temperature; The pharmacodynamic study result shows, this preparation can effectively be treated absolute and relative iron deficiency anemia and due to ferrum intake deficiency or malabsorption, acute or chronic blood loss and infect caused recessiveness or dominant iron deficiency anemia, gestation and anemia age of sucking.The toxicologic study result shows, this preparation toxicity, side effect is lower, and this preparation has wide market prospect.
The specific embodiment
The object of the present invention is achieved like this: take iron protein succinylate as crude drug, add solubilizing agent, and excipient, cosolvent, add the aqueous slkali heated and stirred and dissolve, and adds acid, regulates pH, is made into 800mg/15ml iron protein succinylate oral administration solution.In above-mentioned settled solution, add antiseptic, correctives and sweeting agent, after filtration, sterilizing, be made into iron protein succinylate oral administration solution preparation.
Described solubilizing agent is selected from sodium lauryl sulphate, poloxamer, PEG-400, beta-schardinger dextrin-or above two or more combination in any.
Described excipient is selected from sorbitol, methylcellulose, or above two or more combination in any.
Described cosolvent is selected from 1,2-PD, glycerol, ethanol, or above two or more combination in any.
Described solvent is selected from sodium hydroxide, potassium hydroxide, or above two or more combination in any.
The pH value controlling agent is selected from citric acid, lactic acid, malic acid, or above two or more combination in any.
Antiseptic is selected from methyl hydroxybenzoate sodium, propyl hydroxybenzoate sodium, or above two or more combination in any.
Correctives is selected from Fructus Pyracanthae essence, Fructus Mangifera Indicae essence, the sub-essence of tangerine, cherry essence, or above two or more combination in any.
Sweeting agent is selected from saccharin sodium, steviosin, or above two or more combination in any.
The concrete grammar of iron protein succinylate solubilizing process of the present invention and oral administration solution preparation is as follows:
1. take 0.1-1g iron protein succinylate crude drug, add the 1,2-PD 5-10% of total formulation weight amount, stirring and evenly mixing.
2. the sorbitol 5-10% that adds the total formulation weight amount in above-mentioned solution, stirring and evenly mixing.
3. the sodium lauryl sulphate 0.1-1% or poloxamer 0.1-2% or PEG-400 0.5%-10% or the beta-schardinger dextrin-5-20% that in above-mentioned solution, add the total formulation weight amount, stirring and evenly mixing.
4. in above-mentioned solution, add the KOH solution of the NaOH of 0.1-1mol/L or 0.1-1mol/L or for the combination aqueous slkali heated and stirred of above two kinds of aqueous slkalis to dissolving.
5. the 1-10% citric acid or 1-10% lactic acid or the 1-10% malic acid that in above-mentioned solution, add the total formulation weight amount, regulate pH and put 6.5-8.0, is made into the iron protein succinylate settled solution.
6. 1% essence, the 0.1-0.2% saccharin sodium that in above-mentioned settled solution, add the total formulation weight amount, after 2 μ m filter, again through 0.45 μ m or 0.22 μ m filtering with microporous membrane, and, through 105~115 ℃ of sterilizing 20min of high temperature, can be made into the iron protein succinylate oral administration solution.
Embodiment 1:
Take iron protein succinylate crude drug 0.8g, put in the 100ml beaker, add 1,2-propylene glycol 2ml, sorbitol 1.4g, mix, add sodium lauryl sulphate 0.2g, mix, add 1mol/L NaOH solution to dissolve standardize solution and put 15ml, add the 3g citric acid, regulate pH to 6.5-8.0, add Fructus Pyracanthae essence 1g, saccharin sodium 0.03g, namely be made into the iron protein succinylate oral administration solution, the solution of preparing is after 2 μ m filter, again through 0.45 μ m or 0.22 μ m filtering with microporous membrane, and, through 115 ℃ of sterilizing 20min of high temperature, obtain.
Embodiment 2:
Take iron protein succinylate crude drug 0.8g, put in the 100ml beaker, add 1,2-propylene glycol 2ml, sorbitol 1.4g, mix, and adds poloxamer 0.2g to mix, add 1mol/L NaOH solution to dissolve standardize solution and put 15ml, add the 3g citric acid, regulate pH to 6.5-8.0, add Fructus Pyracanthae essence 1g, saccharin sodium 0.03g, namely be made into the iron protein succinylate oral administration solution, the solution of preparing is after 2 μ m filter, then through 0.45 μ m or 0.22 μ m filtering with microporous membrane, and, through 115 ℃ of sterilizing 20min of high temperature, obtain.
Embodiment 3:
Take iron protein succinylate crude drug 0.8g, put in the 100ml beaker, add 1,2-propylene glycol 2ml, sorbitol 1.4g, mix, add PEG-400 0.2g, mix, add 1mol/L NaOH solution to dissolve standardize solution and put 15ml, add the 3g citric acid, regulate pH to 6.5-8.0, add Fructus Pyracanthae essence 1g, saccharin sodium 0.03g, namely be made into the iron protein succinylate oral administration solution, the solution of preparing is after 2 μ m filter, again through 0.45 μ m or 0.22 μ m filtering with microporous membrane, and, through 115 ℃ of sterilizing 20min of high temperature, obtain.
Embodiment 4:
Take iron protein succinylate crude drug 0.8g, put in the 100ml beaker, add 1,2-propylene glycol 2ml, sorbitol 1.4g, mix, add beta-schardinger dextrin-3g, mix, add 1mol/L NaOH solution to dissolve standardize solution and put 15ml, add the 3g citric acid, regulate pH to 6.5-8.0, add Fructus Pyracanthae essence 1g, saccharin sodium 0.03g, namely be made into the iron protein succinylate oral administration solution, the solution of preparing is after 2 μ m filter, again through 0.45 μ m or 0.22 μ m filtering with microporous membrane, and, through 115 ℃ of sterilizing 20min of high temperature, obtain.
Embodiment 5:Sodium lauryl sulphate, poloxamer, PEG-400, beta-schardinger dextrin-
Take iron protein succinylate crude drug 0.8g, put in the 100ml beaker, add 1,2-propylene glycol 2ml, sorbitol 1.4g, mix, add sodium lauryl sulphate 0.1g, poloxamer 0.1g, mix, add 1mol/L NaOH solution to dissolve standardize solution and put 15ml, add the 3g citric acid, regulate pH to 6.5-8.0, add Fructus Pyracanthae essence 1g, saccharin sodium 0.03g, namely be made into the iron protein succinylate oral administration solution, the solution of preparing is after 2 μ m filter, again through 0.45 μ m or 0.22 μ m filtering with microporous membrane, and, through 115 ℃ of sterilizing 20min of high temperature, obtain.
Embodiment 6:Sodium lauryl sulphate, poloxamer, PEG-400, beta-schardinger dextrin-
Take iron protein succinylate crude drug 0.8g, put in the 100ml beaker, add 1,2-propylene glycol 2ml, sorbitol 1.4g, mix, add sodium lauryl sulphate 0.1g, PEG-400 0.1g, mix, add 1mol/L NaOH solution to dissolve standardize solution and put 15ml, add the 3g citric acid, regulate pH to 6.5-8.0, add Fructus Pyracanthae essence 1g, saccharin sodium 0.03g, namely be made into the iron protein succinylate oral administration solution, the solution of preparing is after 2 μ m filter, again through 0.45 μ m or 0.22 μ m filtering with microporous membrane, and, through 115 ℃ of sterilizing 20min of high temperature, obtain.
Embodiment 7:Sodium lauryl sulphate, poloxamer, PEG-400, beta-schardinger dextrin-
take iron protein succinylate crude drug 0.8g, put in the 100ml beaker, add 1, 2-propylene glycol 2ml, sorbitol 1.4g, mix, add sodium lauryl sulphate 0.1g, poloxamer 0.1, PEG-400 0.1g, mix, add 1mol/L NaOH solution to dissolve standardize solution and put 15ml, add the 3g citric acid, regulate pH to 6.5-8.0, add Fructus Pyracanthae essence 1g, saccharin sodium 0.03g, namely be made into the iron protein succinylate oral administration solution, the solution of preparing is after 2 μ m filter, again through 0.45 μ m or 0.22 μ m filtering with microporous membrane, and through 115 ℃ of sterilizing 20min of high temperature, obtain.
Embodiment 8:Sodium lauryl sulphate, poloxamer, PEG-400, beta-schardinger dextrin-
take iron protein succinylate crude drug 0.8g, put in the 100ml beaker, add 1, 2-propylene glycol 2ml, sorbitol 1.4g, mix, add sodium lauryl sulphate 0.1g, poloxamer 0.1, PEG-400 0.1g, beta-schardinger dextrin-1g, mix, add 1mol/L NaOH solution to dissolve standardize solution and put 15ml, add the 3g citric acid, regulate pH to 6.5-8.0, add Fructus Pyracanthae essence 1g, saccharin sodium 0.03g, namely be made into the iron protein succinylate oral administration solution, the solution of preparing is after 2 μ m filter, again through 0.45 μ m or 0.22 μ m filtering with microporous membrane, and through 115 ℃ of sterilizing 20mi of high temperature.